Home Cart 0 Sign in  
X

[ CAS No. 22084-89-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 22084-89-5
Chemical Structure| 22084-89-5
Chemical Structure| 22084-89-5
Structure of 22084-89-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 22084-89-5 ]

Related Doc. of [ 22084-89-5 ]

Alternatived Products of [ 22084-89-5 ]

Product Details of [ 22084-89-5 ]

CAS No. :22084-89-5 MDL No. :MFCD00079773
Formula : C10H12O2 Boiling Point : -
Linear Structure Formula :- InChI Key :JIRKNEAMPYVPTD-UHFFFAOYSA-N
M.W : 164.20 Pubchem ID :30938
Synonyms :

Calculated chemistry of [ 22084-89-5 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.3
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 47.76
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.53 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.35
Log Po/w (XLOGP3) : 2.49
Log Po/w (WLOGP) : 2.01
Log Po/w (MLOGP) : 2.29
Log Po/w (SILICOS-IT) : 2.36
Consensus Log Po/w : 2.1

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.6
Solubility : 0.414 mg/ml ; 0.00252 mol/l
Class : Soluble
Log S (Ali) : -2.92
Solubility : 0.198 mg/ml ; 0.00121 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.96
Solubility : 0.181 mg/ml ; 0.0011 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.22

Safety of [ 22084-89-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 22084-89-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 22084-89-5 ]
  • Downstream synthetic route of [ 22084-89-5 ]

[ 22084-89-5 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 22084-89-5 ]
  • [ 24644-78-8 ]
YieldReaction ConditionsOperation in experiment
100% With trifluorormethanesulfonic acid In dichloromethane at 80℃; for 1 h; High pressure; Inert atmosphere; Green chemistry General procedure: Trifluoromethane sulfonic acid (3 eq.) was gently added to a cooled (0 °C) solution of a 3-Phenylpropionic acid (0.5 mmol) in dry CH2Cl2 (1.0 mL) in a 12 mL Q-tube™ pressure tube, furnished by QLabtech. The temperature was raised to room temperature. A Teflon septum was placed on the top of the tube and the appropriate cap and pressure adapter were used. The mixture was heated in an oil bath at 80 °C. The reaction was monitored by TLC and GC/MS until the reactant disappeared. The mixture was poured into ice and extracted three times with CH2Cl2. The organic phase collected was dried on Na2SO4, filtered and concentrated under vacuum. The desired pure product was separated from the crude by flash chromatography.
98% at 20℃; Briefly, into a 250-mL round-bottom flask, was placed a solution of 2- methylbenzaldehyde (8 g, 66.58 mmol, 1.00 equiv) in ethanol (80 mL), malonic acid (7.6 g, 73.03 mmol, 1.10 equiv), Pyridine (5 mL). The resulting solution was heated to reflux for 48 hr and allowed to cool to room temperature. The crystalline mass which formed was collect by filtration and washed with ethanol. This resulted in 6 g (55percent) of (E -3-o- tolylacrylic acid as a white solid. Next, into a 250-mL round-bottom flask was placed a solution of (is)-3-o-tolylacrylic acid (12 g, 73.99 mmol, 1.00 equiv) in methanol (80 mL), Palladium carbon (2 g, 10percent). Hydrogen was bubbled into the solution and the resulting solution was stirred overnight at room temperature. The solids were filtered out and the residue was concentrated under vacuum. This resulted in 12 g (98percent) of 3-o-tolylpropanoic acid as colorless oil. Next, a solution of 3-o-tolylpropanoic acid (12 g, 73.08 mmol, 1.00 equiv) in TfOH (70 mL) was placed into a 250-mL round-bottom flask. The resulting solution was stirred overnight at room temperature. Then, ice-water was added and extracted with DCM. The combined organic phases were dried over anhydrous Na2S04. After filtration and concentration, the residue was applied onto a silica gel column with EA/PE=1/100 to 1/50. This resulted in 10.6 g (98percent) of 4-methyl-2,3-dihydroinden-l-one as a white solid. Next, a solution of l-((2-(trimethylsilyl)ethoxy)methyl)-lH-imidazole (270 mg, 1.36 mmol, 1.00 equiv) in tetrahydrofuran (15 mL) was placed into a 100-mL 3- necked round-bottom flask. This was followed by the addition of n-BuLi (0.55 mL, 2.5M) with dropwise under N2 and stirred for 1 h at -70°C. To this was added 4-methyl-2,3- dihydroinden-l-one (200 mg, 1.37 mmol, 1.00 equiv) in tetrahydrofuran (5 mL) dropwise. The reaction mixture was warmed to room temperature over a period of 1 h and the mixture was continued to stir overnight at rt. Then water was added and extracted with EA. The combined organic phases were dried over anhydrous a2S04. After filtration and concentration, the residue was purified by MPLC. This resulted in 250 mg (53percent) of 4- methyl- 1 -(1 -((2-(trimethylsilyl)ethoxy)methyl)- 1 H-imidazol-2-yl)-2,3 -dihydro- 1 H-inden- l-ol as colorless oil. Finally, a solution of 4-methyl-l-(l-((2- (trimethylsilyl)ethoxy)methyl)- 1 H-imidazol-2-yl)-2,3 -dihydro- 1 H-inden- 1 -ol ( 100 mg, 0.29 mmol, 1.00 equiv) in HCOOH (10 mL), Palladium carbon (10 mg) was placed into a 100 mL round bottom flask. The resulting solution was heated to reflux for one overnight. The pH value of the solution was adjusted to 8 with aqueous sodium bicarbonate solution and extracted with EA. The combined organic phases were dried over anhydrous Na2S04. After filtration and concentration, the residue was purified by MPLC. This resulted in 40 mg (67percent) of 2-(4-methyl-2,3-dihydro-lH-inden-l-yl)-lH-imidazole as a white solid. LCMS(m/e) 199 (M+H); XH NMR (300 MHz, CDC13) δ ppm 6.96-7.18 (m, 3H), 6.93 (s, 2H), 4.59 (t, J=8.1 Hz, 1H), 2.80-3.00 (m, 2H), 2.50-2.62 (m, 1H), 2.29 (s, 3H), 2.45-2.29 (s, 1H).
98% at 20℃; Briefly, into a 250-mL round-bottom flask, was placed a solution of 2-methylbenzaldehyde (8 g, 66.58 mmol, 1.00 equiv) in ethanol (80 mL), malonic acid (7.6 g, 73.03 mmol, 1.10 equiv), Pyridine (5 mL). The resulting solution was heated to reflux for 48 hr and allowed to cool to room temperature. The crystalline mass which formed was collect by filtration and washed with ethanol. This resulted in 6 g (55percent) of (E)-3-o-tolylacrylic acid as a white solid. Next, into a 250-mL round-bottom flask was placed a solution of (E)-3-o-tolylacrylic acid (12 g, 73.99 mmol, 1.00 equiv) in methanol (80 mL), Palladium carbon (2 g, 10percent). Hydrogen was bubbled into the solution and the resulting solution was stirred overnight at room temperature. The solids were filtered out and the residue was concentrated under vacuum. This resulted in 12 g (98percent) of 3-o-tolylpropanoic acid as colorless oil. Next, a solution of 3-o-tolylpropanoic acid (12 g, 73.08 mmol, 1.00 equiv) in TfOH (70 mL) was placed into a 250-mL round-bottom flask. The resulting solution was stirred overnight at room temperature. Then, ice-water was added and extracted with DCM. The combined organic phases were dried over anhydrous Na2SO4. After filtration and concentration, the residue was applied onto a silica gel column with EA/PE=1/100 to 1/50. This resulted in 10.6 g (98percent) of 4-methyl-2,3-dihydroinden-1-one as a white solid. Next, a solution of 1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazole (270 mg, 1.36 mmol, 1.00 equiv) in tetrahydrofuran (15 mL) was placed into a 100-mL 3-necked round-bottom flask. This was followed by the addition of n-BuLi (0.55 mL, 2.5M) with dropwise under N2 and stirred for 1 h at −70° C. To this was added 4-methyl-2,3-dihydroinden-1-one (200 mg, 1.37 mmol, 1.00 equiv) in tetrahydrofuran (5 mL) dropwise. The reaction mixture was warmed to room temperature over a period of 1 h and the mixture was continued to stir overnight at rt. Then water was added and extracted with EA. The combined organic phases were dried over anhydrous Na2SO4. After filtration and concentration, the residue was purified by MPLC. This resulted in 250 mg (53percent) of 4-methyl-1-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazol-2-yl)-2,3-dihydro-1H-inden-1-ol as colorless oil. Finally, a solution of 4-methyl-1-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazol-2-yl)-2,3-dihydro-1H-inden-1-ol (100 mg, 0.29 mmol, 1.00 equiv) in HCOOH (10 mL), Palladium carbon (10 mg) was placed into a 100 mL round bottom flask. The resulting solution was heated to reflux for one overnight. The pH value of the solution was adjusted to 8 with aqueous sodium bicarbonate solution and extracted with EA. The combined organic phases were dried over anhydrous Na2SO4. After filtration and concentration, the residue was purified by MPLC. This resulted in 40 mg (67percent) of 2-(4-methyl-2,3-dihydro-1H-inden-1-yl)-1H-imidazole as a white solid. LCMS (m/e) 199 (M+H); 1H NMR (300 MHz, CDC3) δ ppm 6.96-7.18 (m, 3H), 6.93 (s, 2H), 4.59 (t, J=8.1 Hz, 1H), 2.80-3.00 (m, 2H), 2.50-2.62 (m, 1H), 2.29 (s, 3H), 2.45-2.29 (s, 1H).
Reference: [1] Molecules, 2014, vol. 19, # 5, p. 5599 - 5610
[2] Patent: WO2013/74892, 2013, A1, . Location in patent: Page/Page column 39-40
[3] Patent: US9125407, 2015, B2, . Location in patent: Page/Page column 27; 28
[4] Chemistry - A European Journal, 2017, vol. 23, # 53, p. 13037 - 13041
[5] Phosphorus, Sulfur and Silicon and the Related Elements, 1994, vol. 91, # 1-4, p. 69 - 80
[6] Louvain Medical, 1974, vol. 93, # 4, p. 189 - 194
[7] Journal of the Chemical Society, 1957, p. 592,598
[8] Journal of the Chemical Society, 1958, p. 2536,2538
[9] Chemische Berichte, 1892, vol. 25, p. 2106
[10] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 16, p. 460
[11] Journal of the Chemical Society, 1961, p. 3958 - 3962
[12] Journal of the Indian Chemical Society, 1955, vol. 32, p. 403,409
[13] Tetrahedron Letters, 1981, vol. 22, p. 1093 - 1096
[14] Journal of Organic Chemistry, 1982, vol. 47, # 11, p. 2120 - 2125
[15] Journal of Organic Chemistry, 1981, vol. 46, # 14, p. 2974 - 2976
[16] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1999, vol. 38, # 4, p. 407 - 412
[17] Journal of Medicinal Chemistry, 2003, vol. 46, # 3, p. 399 - 408
[18] Journal of Medicinal Chemistry, 1997, vol. 40, # 19, p. 3014 - 3024
[19] Helvetica Chimica Acta, 1940, vol. 23, p. 907,909
[20] Journal of the Indian Chemical Society, 1943, vol. 20, p. 393,398
[21] Journal of the Chemical Society, 1936, p. 288
[22] Patent: US5177075, 1993, A,
[23] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 16, p. 460
  • 2
  • [ 22084-89-5 ]
  • [ 24644-78-8 ]
Reference: [1] Monatshefte fur Chemie, 2001, vol. 132, # 2, p. 267 - 278
  • 3
  • [ 22084-89-5 ]
  • [ 7664-93-9 ]
  • [ 24644-78-8 ]
Reference: [1] Chemische Berichte, 1892, vol. 25, p. 2106
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 22084-89-5 ]

Aryls

Chemical Structure| 6057-60-9

[ 6057-60-9 ]

4-(4-Biphenylyl)butyric acid

Similarity: 0.97

Chemical Structure| 35888-99-4

[ 35888-99-4 ]

3-([1,1'-Biphenyl]-4-yl)propanoic acid

Similarity: 0.97

Chemical Structure| 26114-12-5

[ 26114-12-5 ]

2-(4-Propylphenyl)acetic acid

Similarity: 0.93

Chemical Structure| 71367-28-7

[ 71367-28-7 ]

3,3'-(Anthracene-9,10-diyl)dipropanoic acid

Similarity: 0.93

Chemical Structure| 7500-53-0

[ 7500-53-0 ]

2,2'-(1,2-Phenylene)diacetic acid

Similarity: 0.93

Carboxylic Acids

Chemical Structure| 6057-60-9

[ 6057-60-9 ]

4-(4-Biphenylyl)butyric acid

Similarity: 0.97

Chemical Structure| 35888-99-4

[ 35888-99-4 ]

3-([1,1'-Biphenyl]-4-yl)propanoic acid

Similarity: 0.97

Chemical Structure| 26114-12-5

[ 26114-12-5 ]

2-(4-Propylphenyl)acetic acid

Similarity: 0.93

Chemical Structure| 71367-28-7

[ 71367-28-7 ]

3,3'-(Anthracene-9,10-diyl)dipropanoic acid

Similarity: 0.93

Chemical Structure| 7500-53-0

[ 7500-53-0 ]

2,2'-(1,2-Phenylene)diacetic acid

Similarity: 0.93